Sylvain Pilorge

577 total citations
17 papers, 191 citations indexed

About

Sylvain Pilorge is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Sylvain Pilorge has authored 17 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Hematology and 6 papers in Genetics. Recurrent topics in Sylvain Pilorge's work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Sylvain Pilorge is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Sylvain Pilorge collaborates with scholars based in France, Germany and United States. Sylvain Pilorge's co-authors include Toshiro Kawakita, Michael Henry Schmitt, Valerie Teal, Christine Terré, Matthias Stelljes, Cyrus Badshah, Domenico Russo, Sophie Rigaudeau, Sylvie Castaigné and Sanjeet Dadwal and has published in prestigious journals such as Blood, Journal of Medical Microbiology and Haematologica.

In The Last Decade

Sylvain Pilorge

16 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvain Pilorge France 7 85 64 62 42 41 17 191
Vincenzo Cassibba Italy 6 56 0.7× 42 0.7× 77 1.2× 43 1.0× 36 0.9× 12 190
Chiara Quadrelli Italy 8 90 1.1× 23 0.4× 40 0.6× 57 1.4× 22 0.5× 13 174
Lingaraj Nayak India 8 80 0.9× 18 0.3× 66 1.1× 28 0.7× 19 0.5× 64 204
Kyoya Kumagai Japan 9 103 1.2× 39 0.6× 52 0.8× 115 2.7× 18 0.4× 33 271
Vincenzo Mettivier Italy 10 57 0.7× 60 0.9× 115 1.9× 58 1.4× 85 2.1× 13 262
Raimundo García Spain 7 93 1.1× 38 0.6× 163 2.6× 67 1.6× 40 1.0× 8 279
Tamara Belotti Italy 10 31 0.4× 23 0.4× 50 0.8× 37 0.9× 18 0.4× 16 163
Ram Vasudevan Nampoothiri India 8 28 0.3× 19 0.3× 91 1.5× 34 0.8× 28 0.7× 49 184
Angela Passi Italy 8 59 0.7× 21 0.3× 117 1.9× 38 0.9× 62 1.5× 12 200
Ching‐Hon Pui United States 7 68 0.8× 47 0.7× 80 1.3× 19 0.5× 30 0.7× 11 288

Countries citing papers authored by Sylvain Pilorge

Since Specialization
Citations

This map shows the geographic impact of Sylvain Pilorge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Pilorge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Pilorge more than expected).

Fields of papers citing papers by Sylvain Pilorge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Pilorge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Pilorge. The network helps show where Sylvain Pilorge may publish in the future.

Co-authorship network of co-authors of Sylvain Pilorge

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Pilorge. A scholar is included among the top collaborators of Sylvain Pilorge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Pilorge. Sylvain Pilorge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
Saleh, Khalil, David Ghez, Camille Bigenwald, et al.. (2023). Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation. Immunotherapy. 15(6). 401–407. 2 indexed citations
4.
Honoré, Charles, Olivier Mir, Arthur Géraud, et al.. (2021). Intercontinental Multidisciplinary Oncology Videoconferencing for Rare and Complex Cancer: An Alternative to Systematic Transfer. JCO Oncology Practice. 17(9). e1311–e1317. 3 indexed citations
5.
Lapierre, Valérie, Téreza Coman, Nolwenn Lucas, et al.. (2020). Donor Lymphocyte Infusions After Allogeneic Transplantation: A Single-Center Experience. Clinical Lymphoma Myeloma & Leukemia. 20(4). 209–211. 6 indexed citations
6.
Lapierre, Valérie, Téreza Coman, Nolwenn Lucas, et al.. (2019). Donor Lymphocyte Infusions After Allogeneic Transplantation: A Single Center Experience. Clinical Lymphoma Myeloma & Leukemia. 19. S263–S264. 1 indexed citations
7.
Turpin, Anthony, Jean‐Marie Michot, Emmanuelle Kempf, et al.. (2017). Le lymphome de Hodgkin : stratégies thérapeutiques actuelles et futures. Bulletin du Cancer. 105(1). 81–98. 3 indexed citations
8.
Saleh, Khalil, Alina Danu, Serge Koscielny, et al.. (2017). A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience. Leukemia & lymphoma. 59(11). 2580–2587. 14 indexed citations
9.
Willems, Lise, Bénédicte Deau, Sylvain Pilorge, et al.. (2016). Polyserositis in the course of chronic myelomonocytic leukemia: impact of hypomethylating agents. 2(1). 126–130. 2 indexed citations
10.
Ribrag, Vincent, Khalil Saleh, Alina Danu, et al.. (2016). BEAM or BeEAM High-Dose Chemotherapy Followed By ASCT: A Single Center Comparative Analysis of Toxicity. Blood. 128(22). 4648–4648. 3 indexed citations
11.
Woerther, Paul‐Louis, Jean‐Baptiste Micol, Cécile Angebault, et al.. (2015). Monitoring antibiotic-resistant enterobacteria faecal levels is helpful in predicting antibiotic susceptibility of bacteraemia isolates in patients with haematological malignancies. Journal of Medical Microbiology. 64(7). 676–681. 12 indexed citations
12.
13.
Pilorge, Sylvain, Sophie Rigaudeau, Florence Rabian, et al.. (2013). Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse. American Journal of Hematology. 89(4). 399–403. 19 indexed citations
14.
Sarkozy, Clémentine, Christine Terré, Fabrice Jardin, et al.. (2013). Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index. Genes Chromosomes and Cancer. 53(1). 106–116. 49 indexed citations
15.
Wetzler, Meir, Jessica Kohlschmidt, Krzysztof Mrózek, et al.. (2011). Prognostic Significance of Karyotype in Octogenarian Patients (Pts) with Acute Myeloid Leukemia (AML)–An International Study. Blood. 118(21). 2521–2521. 1 indexed citations
16.
Thépot, Sylvain, Raphaël Itzykson, Emmanuel Raffoux, et al.. (2008). Treatment of Progression of Myeloproliferative Disorders(MPD) to MDS/AML by Azacytidine (AZA) : A Preliminary Report on 17 Patients (pts). Blood. 112(11). 2800–2800. 1 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Cassibba Breakdown of academic impact, for papers by Chiara Quadrelli Breakdown of academic impact, for papers by Lingaraj Nayak Breakdown of academic impact, for papers by Kyoya Kumagai Breakdown of academic impact, for papers by Vincenzo Mettivier Breakdown of academic impact, for papers by Raimundo García Breakdown of academic impact, for papers by Tamara Belotti Breakdown of academic impact, for papers by Ram Vasudevan Nampoothiri Breakdown of academic impact, for papers by Angela Passi Breakdown of academic impact, for papers by Ching‐Hon Pui
Rankless by CCL
2026